DYNAMICS OF CLINICAL AND LABORATORY INDICATORS IN THE TREATMENT OF PATIENTS WITH PSORIASIS AND CONCOMITANT ALIMENTARY OBESITY

Authors:

Abstract:

Psoriasis is the most common chronic, genetically determined autoimmune polyetiological inflammatory disease with impaired epidermal proliferation, which is provoked by exogenous and endogenous factors and is manifested by erythematous and scaly elements, papules and plaques. There is still no consensus on the pathogenesis of this dermatosis. To objectively understand the pathogenesis of psoriasis, it is necessary to take into account the insufficiently studied comorbidity of this pathology. Numerous studies have shown a clear link between psoriasis and obesity. Systemic inflammation is a common link in the pathogenesis of obesity and psoriasis. In this study, we determined the effectiveness of standard treatment for patients with psoriasis and concomitant grade I-II alimentary obesity, by clinical and immunological examination of systemic inflammation. Found that the treatment of patients was ineffective and further led to the deterioration of patient’s condition due to increased systemic inflammation, the progression of obesity and a more severe course of psoriasis.

Keywords:

psoriasis alimentary obesity pathogenesis clinical presentation

References:

1. Babak OYa, Yarmish NV, Shkolnik VV. Ozhirіnnya yak puskoviy mehanіzm adipocitokіnovoho kaskadu. Medicina transportu Ukrainy. 2012; 2: 94-99. [in Ukrainian]
2. Yemchenko Ya. Riven pokaznykiv systemnoho zapalennia u khvorykh na psoriaz obtiazhenyi metabolichnym syndromom. Zhurnal dermatovenerolohiyi ta kosmetolohiyi imeni M.O.Torsueva. 2018; 1 (38):31-35. [in Ukrainian]
3. Kaydashev IP. Izmeneniye obraza zhizni, narusheniye energeticheskogo metabolizma i sistemnoye vospaleniye kak faktory razvitiya bolezney tsivilizatsii. Ukrayinskyi medychnyi chasopys. 2013; 5: 103-108. [in Ukrainian]
4. Kamylov FKh, Mufazalova NA, Kapuler OM. Tsytokinovyi dysbalans v immunopatogeneze psoriaza. Fundamentalni doslidzhennia. 2015; 1 (5):1065-1071. [in Russian]
5. Atkinson RL. Could viruses contribute to the worldwide epidemic of obesity Int J Pediat Obes. 2018; 3: Suppl 1: 37-43.
6. Bertheloot D, Latz E. HMGB1, IL-1a, IL-33 and S100 proteins: dualfunction alarmins. Cell Mol Immunol. 2017; 14(1):43-64.
7. Brikos C, O´Neill LA. Signaling of toll-like receptors. Handb Exp Pharmacol. 2018; 183: 21-50.
8. Clark RA. Resident memory T cells in human health and disease. Sci Transl Med. 2015; 7 (269):269-274.
9. Mitsui A, Tada Y, Takahashi T, Shibata S, Kamata M. Serum IL 33 levels are increased in patients with psoriasis. Experimental dermatology. 2015; 3(2):234-239.
10. Fredriksson T, Pettersson U. Severe psoriasis—oral therapy with a new retinoid. Dermatologica. 1978; 157(4):238-44. PMID 357213.
11. Harden JL, Krueger JG, Bowcock AM. The immunogenetics of Psoriasis: A comprehensive review. J Autoimmun. 2015 Nov; 64:66-73.
12. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI). The practical guide: identification, evaluation, and treatment of overweight and obesity in adults. Bethesda: National Institutes of Health. 2000, NIH publication 00-4084.
13. Suganami T, Tanimoto-Koyama K, Nishida J. Role of the Tolllike receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol. 2017; 27: 84-91.

Publication:

«World of Medicine and Biology» Vol. 17 No. 75 (2021) , с. 55-58
УДК 616.517-056.5-08-071

DOI:

https://doi.org/10.26724/2079-8334-2021-1-75-55-58